MiR-93 regulates translocation of liposarcoma 1 (TLS1, FUS1), transducin repeat containing 2 (TRCP2), and disabled homolog 2 (DAB2), and plays an oncogenic role in lung cancer carcinogenesis. Here, C9orf78 is linked to lung carcinoma.